These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 231031

  • 1. [Recent notions concerning the treatments used in multiple sclerosis (author's transl)].
    Gonsette RE.
    J Belge Med Phys Rehabil; 1978; 1(3):213-6. PubMed ID: 231031
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Selected methods of current treatment of multiple sclerosis].
    Orłowska E.
    Neurol Neurochir Pol; 1980; 14(3):321-5. PubMed ID: 6158011
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of patients with multiple sclerosis with transfer factor (author's transl)].
    Romano EL, Pulido M, Layrisse Z, Malavé I.
    Acta Cient Venez; 1978; 29(1):49-52. PubMed ID: 757718
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Review of the therapy of multiple sclerosis].
    De Rosa A, Puccini A, De Martino V.
    Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
    [No Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
    Cendrowski WS.
    Schweiz Arch Neurol Neurochir Psychiatr; 1969 Dec; 105(2):241-6. PubMed ID: 4314087
    [No Abstract] [Full Text] [Related]

  • 9. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U, Majeron M, Mascetti A.
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb 29; 96(1):163-84. PubMed ID: 4337775
    [No Abstract] [Full Text] [Related]

  • 10. Prospects for the treatment of multiple sclerosis.
    Hughes RA.
    J R Soc Med; 1991 Feb 29; 84(2):63-5. PubMed ID: 1847975
    [No Abstract] [Full Text] [Related]

  • 11. [ACTH treatment of multiple sclerosis].
    Boman K, Hokkanen E, Jarho L, Kivalo E.
    Duodecim; 1966 Feb 29; 82(18):867-73. PubMed ID: 4288673
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A critical evaluation and review of ACTH (corticotrophin) in the treatment of acute exacerbations of multiple sclerosis.
    Blustein H, Wasserman RR, Halperin L, Garvin JS.
    Med Times; 1969 Dec 29; 97(12):137-41. PubMed ID: 4312534
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment and prevention of myelin disorders: multiple sclerosis.
    Abramsky O.
    Bull Soc Belge Ophtalmol; 1983 Nov 29; 208 Pt 1():489-92. PubMed ID: 6326915
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Immunological aspects of multiple sclerosis].
    Bakouche P.
    Munch Med Wochenschr; 1969 Sep 26; 111(39):1985-7. PubMed ID: 4309930
    [No Abstract] [Full Text] [Related]

  • 18. [Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents].
    Skłodowski P.
    Neurol Neurochir Pol; 1993 Sep 26; 27(6):877-83. PubMed ID: 8164783
    [Abstract] [Full Text] [Related]

  • 19. [Immunosuppressive treatment in neurological disorders].
    Aarli JA.
    Tidsskr Nor Laegeforen; 1973 Jun 30; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract] [Full Text] [Related]

  • 20. [Attempt at treating multiple sclerosis with delayed-action corticotropin].
    Cendrowski W.
    Neurol Neurochir Pol; 1972 Jun 30; 6(3):381-6. PubMed ID: 4338088
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.